A large exercise of company stock options by Patrick Mayes, EVP & Chief Scientific Officer at Incyte (NASDAQ:INCY) was disclosed in a new SEC filing on January 21, as part of an insider exercise. What ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results